Cargando…

Whole-Body Functional MRI and PET/MRI in Multiple Myeloma

SIMPLE SUMMARY: Whole-body magnetic resonance imaging (MRI) is recognized as the most sensitive imaging technique for the detection of bone marrow infiltration, and was therefore, recently included in the new diagnostic myeloma criteria, as proposed by the International Myeloma Working Group. The us...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulé, Sébastien, Reizine, Edouard, Blanc-Durand, Paul, Baranes, Laurence, Zerbib, Pierre, Burns, Robert, Nouri, Refaat, Itti, Emmanuel, Luciani, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693006/
https://www.ncbi.nlm.nih.gov/pubmed/33121132
http://dx.doi.org/10.3390/cancers12113155
_version_ 1783614644613545984
author Mulé, Sébastien
Reizine, Edouard
Blanc-Durand, Paul
Baranes, Laurence
Zerbib, Pierre
Burns, Robert
Nouri, Refaat
Itti, Emmanuel
Luciani, Alain
author_facet Mulé, Sébastien
Reizine, Edouard
Blanc-Durand, Paul
Baranes, Laurence
Zerbib, Pierre
Burns, Robert
Nouri, Refaat
Itti, Emmanuel
Luciani, Alain
author_sort Mulé, Sébastien
collection PubMed
description SIMPLE SUMMARY: Whole-body magnetic resonance imaging (MRI) is recognized as the most sensitive imaging technique for the detection of bone marrow infiltration, and was therefore, recently included in the new diagnostic myeloma criteria, as proposed by the International Myeloma Working Group. The use of diffusion-weighted MRI further improved the performances of whole-body MRI in the setting of multiple myeloma, and its systematic implementation in general clinical practice is now recommended. Whole-body, dynamic, contrast-enhanced MRI might provide further information on lesions vascularity and might help evaluate response to treatment. Hybrid PET/MRI might act as the optimal imaging modality, owing to the association of the best techniques for both detecting bone marrow involvement and evaluating treatment response, providing one-stop-shop imaging in a whole-body scale. This review provides an overview on the value of whole-body MRI, including diffusion-weighted and dynamic contrast-enhanced MRI and whole-body (18)F-FDG PET/MRI in diagnosis, staging, and response evaluation in multiple myeloma. ABSTRACT: Bone disease is one of the major features of multiple myeloma (MM), and imaging has a pivotal role in both diagnosis and follow-up. Whole-body magnetic resonance imaging (MRI) is recognized as the gold standard for the detection of bone marrow involvement, owing to its high sensitivity. The use of functional MRI sequences further improved the performances of whole-body MRI in the setting of MM. Whole-body diffusion-weighted (DW) MRI is the most attractive functional technique and its systematic implementation in general clinical practice is now recommended by the International Myeloma Working Group. Whole-body dynamic contrast-enhanced (DCE) MRI might provide further information on lesions vascularity and help evaluate response to treatment. Whole Body PET/MRI is an emerging hybrid imaging technique that offers the opportunity to combine information on morphology, fat content of bone marrow, bone marrow cellularity and vascularization, and metabolic activity. Whole-body PET/MRI allows a one-stop-shop examination, including the most sensitive technique for detecting bone marrow involvement, and the most recognized technique for treatment response evaluation. This review aims at providing an overview on the value of whole-body MRI, including DW and DCE MRI, and combined whole-body (18)F-FDG PET/MRI in diagnosis, staging, and response evaluation in patients with MM.
format Online
Article
Text
id pubmed-7693006
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76930062020-11-28 Whole-Body Functional MRI and PET/MRI in Multiple Myeloma Mulé, Sébastien Reizine, Edouard Blanc-Durand, Paul Baranes, Laurence Zerbib, Pierre Burns, Robert Nouri, Refaat Itti, Emmanuel Luciani, Alain Cancers (Basel) Review SIMPLE SUMMARY: Whole-body magnetic resonance imaging (MRI) is recognized as the most sensitive imaging technique for the detection of bone marrow infiltration, and was therefore, recently included in the new diagnostic myeloma criteria, as proposed by the International Myeloma Working Group. The use of diffusion-weighted MRI further improved the performances of whole-body MRI in the setting of multiple myeloma, and its systematic implementation in general clinical practice is now recommended. Whole-body, dynamic, contrast-enhanced MRI might provide further information on lesions vascularity and might help evaluate response to treatment. Hybrid PET/MRI might act as the optimal imaging modality, owing to the association of the best techniques for both detecting bone marrow involvement and evaluating treatment response, providing one-stop-shop imaging in a whole-body scale. This review provides an overview on the value of whole-body MRI, including diffusion-weighted and dynamic contrast-enhanced MRI and whole-body (18)F-FDG PET/MRI in diagnosis, staging, and response evaluation in multiple myeloma. ABSTRACT: Bone disease is one of the major features of multiple myeloma (MM), and imaging has a pivotal role in both diagnosis and follow-up. Whole-body magnetic resonance imaging (MRI) is recognized as the gold standard for the detection of bone marrow involvement, owing to its high sensitivity. The use of functional MRI sequences further improved the performances of whole-body MRI in the setting of MM. Whole-body diffusion-weighted (DW) MRI is the most attractive functional technique and its systematic implementation in general clinical practice is now recommended by the International Myeloma Working Group. Whole-body dynamic contrast-enhanced (DCE) MRI might provide further information on lesions vascularity and help evaluate response to treatment. Whole Body PET/MRI is an emerging hybrid imaging technique that offers the opportunity to combine information on morphology, fat content of bone marrow, bone marrow cellularity and vascularization, and metabolic activity. Whole-body PET/MRI allows a one-stop-shop examination, including the most sensitive technique for detecting bone marrow involvement, and the most recognized technique for treatment response evaluation. This review aims at providing an overview on the value of whole-body MRI, including DW and DCE MRI, and combined whole-body (18)F-FDG PET/MRI in diagnosis, staging, and response evaluation in patients with MM. MDPI 2020-10-27 /pmc/articles/PMC7693006/ /pubmed/33121132 http://dx.doi.org/10.3390/cancers12113155 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mulé, Sébastien
Reizine, Edouard
Blanc-Durand, Paul
Baranes, Laurence
Zerbib, Pierre
Burns, Robert
Nouri, Refaat
Itti, Emmanuel
Luciani, Alain
Whole-Body Functional MRI and PET/MRI in Multiple Myeloma
title Whole-Body Functional MRI and PET/MRI in Multiple Myeloma
title_full Whole-Body Functional MRI and PET/MRI in Multiple Myeloma
title_fullStr Whole-Body Functional MRI and PET/MRI in Multiple Myeloma
title_full_unstemmed Whole-Body Functional MRI and PET/MRI in Multiple Myeloma
title_short Whole-Body Functional MRI and PET/MRI in Multiple Myeloma
title_sort whole-body functional mri and pet/mri in multiple myeloma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693006/
https://www.ncbi.nlm.nih.gov/pubmed/33121132
http://dx.doi.org/10.3390/cancers12113155
work_keys_str_mv AT mulesebastien wholebodyfunctionalmriandpetmriinmultiplemyeloma
AT reizineedouard wholebodyfunctionalmriandpetmriinmultiplemyeloma
AT blancdurandpaul wholebodyfunctionalmriandpetmriinmultiplemyeloma
AT baraneslaurence wholebodyfunctionalmriandpetmriinmultiplemyeloma
AT zerbibpierre wholebodyfunctionalmriandpetmriinmultiplemyeloma
AT burnsrobert wholebodyfunctionalmriandpetmriinmultiplemyeloma
AT nourirefaat wholebodyfunctionalmriandpetmriinmultiplemyeloma
AT ittiemmanuel wholebodyfunctionalmriandpetmriinmultiplemyeloma
AT lucianialain wholebodyfunctionalmriandpetmriinmultiplemyeloma